Fresenius Kabi AG
Company Snapshot
Founded: 1999
Entity Type: Private
Employees: 41,000
Region: Germany
Revenue: $9,105.7 Millions
Revenue Year: 2024
Headquarter: Bad Homburg , Germany
Key Geographics: Europe, North America, Latin America, Asia-Pacific, Africa
Company Overview
Fresenius Kabi is one of four business segments of Fresenius SE & Co. KGaA, a European diversified healthcare company based in Bad Homburg, Germany. The Fresenius Group offers products and services for dialysis, hospitals, and inpatient and outpatient medical care. The company’s product offerings cater to various therapeutic areas, including oncology, diabetes, maldigestion, critical care, liver and renal insufficiency, pediatrics, and blood volume substitution. Fresenius is developing biosimilar products in the areas of immunology and oncology.
Financial Highlights (FY 2024)
Net Revenue: ***
Operating Income: ***
This information is available for BCC Research members only.
Fresenius Kabi AG In News
Applications/End User Industries
- Hospitals
- Healthcare Professionals
- Oncology
- Long-Term Care Facilities
- Clinics
- Nephrology
- Pediatrics
- Geriatrics
- Surgery
- Enteral Nutrition
- Parenteral Nutrition
- Ambulatory
- Analgesia
- Anesthetics
- Critical Care Drugs
- Alternate Care Sites
- Research Labs
- Blood And Plasma Collection Centers
BCC Research Beacon 